24th International Prostate Cancer Update

Vail, Colorado
Wednesday, February 19, 2014

24th International Prostate Cancer Update

Wednesday, February 19, 2014 - Saturday, February 22, 2014
Cascade Conference Center
Vail, Colorado

FACULTY

Program Chair

E. David Crawford, MD
University of Colorado, Denver
Aurora, Colorado





Program Committee

James A. Eastham, MD
Memorial Sloan-Kettering Cancer Center
New York, NY
Alan W. Partin, MD, PhD
Johns Hopkins Medical Institutions
Baltimore, MD
Leonard G. Gomella, MD
Thomas Jefferson University
Philadelphia, PA
Daniel P. Petrylak, MD
Yale Cancer Center
New Haven, CT
M. Scott Lucia, MD
University of Colorado, Denver School of Medicine
Aurora, CO
Neal D. Shore, MD
Atlantic Urology Clinics, LLC 
Myrtle Beach, SC

Invited Faculty

Sean P. Collins, MD, PhD
Georgetown University Hospital Washington, DC
Peter F. A. Mulders, MD, PhD
Radboud University Medical Center
Nijmegen, The Netherlands
James A. Eastham, MD
Memorial Sloan-Kettering Cancer Center
New York, NY
Alan W. Partin, MD, PhD
Johns Hopkins Medical Institutions
Baltimore, MD
L. Michael Glodé
University of Colorado, Denver School of Medicine
Aurora, CO
Daniel P. Petrylak, MD
Yale Cancer Center
New Haven, CT
Leonard G. Gomella, MD
Thomas Jefferson University
Philadelphia, PA
Peter A. Pinto, MD
U.S. National Institutes of Health
Bethesda, MD
Aaron E. Katz, MD
Winthrop-University Hospital
Mineola, NY
Matt T. Rosenberg, MD
Urologic Health Foundation
Jackson, Michigan
Thomas E. Keane, MBBCh
Medical University of South Carolina 
Charleston, SC
Neal D. Shore, MD
Atlantic Urology Clinics, LLC 
Myrtle Beach, SC
Phillip J. Koo, MD
University of Colorado, Denver School of Medicine
Aurora, CO
Nelson N. Stone, MD
Mount Sinai School of Medicine
Mount Sinai School of Medicine
New York, NY
M. Scott Lucia, MD
University of Colorado, Denver School of Medicine
Aurora, CO
Priya N. Werahera, PhD
University of Colorado, Denver School of Medicine
Aurora, CO
Brian J. Moran, MD
Chicago Prostate Center
Westmont, IL


AGENDA

Wednesday February 19, 2014

12:00-5:00pm  Registration and Exhibitor Check-in 
Evening  On Own 

Thursday, February 20, 2014

6:30-7:30am  Breakfast 
7:30-10:30am Exhibits
7:30-7:45am Welcome and Introduction
–– 
E. David Crawford, MD, Program Chair 

SESSION I: BIOMARKERS UPDATE

7:45-8:05am  Novel Blood and Urine Tests for Prostate Cancer Diagnosis –– Alan W. Partin, MD, PhD 
8:05-8:25am  SNP’s for Prostate Cancer Risk Stratification –– Alan W. Partin, MD, PhD 
8:25-8:45am  Gene Expression Assays for Prognostic Value –– M. Scott Lucia, MD 
8:45-9:05am  MRI and Biomarkers: Targeting Treatment Decisions in Prostate Cancer ––Peter F. A. Mulders, MD, PhD
9:20-9:40am  CTC/DTC for Prognostic Value for Prostate Cancer –– M. Scott Lucia, MD
9:40-10:30am Panel Discussion and Case Studies –– Moderators: Alan W. Partin, MD, PhD and M. Scott Lucia, MD with Panelists L. Michael Glodé, MD, Leonard G. Gomella, MD, Peter F. A. Mulders, MD, PhD, and E. David Crawford, MD
10:30am  Morning Session Adjourns 
12:00-1:30pm  Industry-Supported Lunch Symposium
3:30-7:00pm Exhibits 

SESSION II: LOCALIZED DISEASE – Part 1 

3:30-3:50pm  A Review of the 2013 AUA Guidelines on Early Detection of PCa –– Alan W. Partin, MD, PhD
3:50-4:10pm  MRI-US Fused Imaging in Prostate Cancer: Targeted Biopsy vs. Standard Biopsy
vs. Template Biopsy –– 
Peter A. Pinto, MD 
4:10-4:30pm  Testosterone Replacement in the Prostate Cancer Patient –– Leonard G. Gomella, MD
4:30-4:50pm  Discussion 
5:10-5:30pm  Adjuvant and Salvage Radiotherapy After Prostatectomy:
A Review of the 2013 ASTRO/AUA Guidelines –– 
Nelson N. Stone, MD 
5:30-5:50pm Can Radiation Toxicity and Response be Predicted by Genetics? –– Nelson N. Stone, MD 
5:50-6:10pm  Diet, Supplements & PSA Recurrence –– Aaron E. Katz, MD 
6:10-7:00pm  Discussion 
7:00-8:30pm  Poster Sessions and Welcome Wine and Cheese Reception 

Friday, February 21, 2014

6:30-7:30am  Industry-Supported Breakfast Symposium
7:30-10:30am  Exhibits 

SESSION III: LOCALIZED DISEASE – Part 2

7:45-8:00am
Why There Is A Need for Focal Therapy Treatment –– Brian J. Moran, MD
8:00-8:15am
Androgen Deprivation Therapy (ADT) with GnRH Antagonists –– Thomas E. Keane, MD
8:15-8:30am
 Radiosurgery for Prostate Cancer with the CyberKnife® –– Sean P. Collins, MD
8:50-9:10am
Precision Biopsy –– Priya N. Werahera, PhD
9:10-9:30am
Advances in PET Imaging –– Phillip J. Koo
9:30-10:00am Debate on Salvage Prostatectomy Options
    9:30-9:45am Robotic Salvage Prostatectomy –– James A. Eastham, MD
    9:45-10:00am Salvage Cryotherapy –– Aaron E. Katz
10:00-11:00am Panel Discussion and Case Studies
11:15am-12:30pm  Industry-Supported Lunch Symposium
 3:30-6:30pm  Exhibits

 SESSION IV: ADVANCED AND METASTATIC DISEASE 

3:30-3:50pm  State-of-The-Art Advanced Treatment Landscape
–– 
E. David Crawford, MD 
4:00-4:20pm Advances in Focal Ablative Treatment of Prostate Cancer ––James A. Eastham, MD
4:20-4:50pm  Patient Profile and The Effect of Novel Hormonal Therapies –– Peter F. A. Mulders, MD, PhD
4:50-5:20pm  Avoiding Toxicity in ADT –– Leonard G. Gomella, MD
5:20-6:30pm  Panel Discussion and Case Studies 
6:30-7:30pm  Reception and Keynote Address  

Saturday, February 22, 2014

6:30-7:30am  Industry-Supported Breakfast Symposium 
7:30-11:30am   Exhibits

SESSION V: TREATMENT OF ADVANCED AND CASTRATION-RESISTANT DISEASE 

7:30-7:50am  The Latest on Chemotherapeutic Approaches –– Daniel P. Petrylak, MD 
7:50-8:10am  Update on Vaccine and Immunotherapy –– Neal D. Shore, MD 
8:10-8:30am  New Oral Androgen Receptor Pathway Agents Are Changing the Way Prostate Cancer
Is Treated –– 
Leonard G. Gomella, MD 
8:30-8:50am  Bone-targeted Therapies and Radiopharmaceuticals –– Daniel P. Petylak, MD 
8:50-9:10am  Multimodal Treatment of mCRPC: Potential Sequencing of Newer Agents –– Neal D. Shore, MD
9:10-9:45am  Discussion 
 9:45-10:00am Coffee Break 

SESSION VI: THE FUTURE OF MEN'S HEALTH

10:00-10:20am The Latest in Earlier Stage Clinical Trials for Prostate Cancer –– Neal D. Shore, MD 
10:20-10:40am  Multidisciplinary Treatment for Urologic Cancers at Thomas Jefferson University –– Leonard G. Gomella, MD 
10:40-11:00am  How the PSA Guidelines Missed the Mark with Primary Care, and How to Fix Them –– Matt T. Rosenberg, MD 
11:00-11:45am  Panel Discussion of Treatment of PCa: The Multidisciplinary Approach –– Moderator: Matt T. Rosenberg, MD, with Panelists E. David Crawford, MD, Daniel P. Petrylak, MD, Neal D. Shore, MD, Leonard G. Gomella, MD, James A. Eastham, MD, Alan W. Partin, MD, PhD, and M. Scott Lucia, MD 
11:45am  Announcement of Winning Poster and Closing Remarks 
 

Contact Information

  • Carden Jennings Publishing, Co., Ltd.
    Contact: David Utz
    Phone: 434-817-2000 ext. 152, Email: dutz@cjp.com

Payment Instructions

  • Payment with credit card can be made via this website. If paying by check, make checks payable to Carden Jennings Publishing Co., Ltd. and addressed to:

    Carden Jennings Publishing Co., Ltd.
    375 Greenbrier Drive, Suite 100
    Charlottesville, VA 22901

    Call for Abstracts

    You are invited to submit an abstract reflecting your latest findings in the fields of prostate cancer management and prevention. Authors of accepted submissions will be invited to display a poster at the meeting, as well as give a brief oral presentation.

    Submission of Abstract

    Please submit an abstract of 500 words or less (single-spaced, 10-point size); include a title for the abstract

    Spell out complete names of all authors

    List the institution, city, state, country, and e-mail address of the presenting author

    E-mail the document to liz@cjp.com

    The deadline for submitting abstracts for the 24th International Prostate Cancer Update is December 20, 2013.